Coronavirus Notebook: UK Adds Paxlovid To PANORAMIC Study, Germany Funds Adrecizumab Phase II Trial

 
• By Ian Schofield

RedHill’s opaganib has shown “potent inhibition” of the Omicron variant in early studies, while the EMA has found no links between the mRNA vaccines and autoimmune hepatitis.

Immunological system, antibodies attacking the virus covid-19.
A number of therapies are being tested in different COVID-19 settings • Source: Alamy

More from Europe

More from Geography